. 2020 Jul 2;27(1):938–952. doi: 10.1080/10717544.2020.1785052

Table 1.

Results of LVEDD, LVESD, LVEDV, LVESV, LVEF and LVFS in experimental animals (n = 10).

Group	LVEDD (mm)	LVESD (mm)	LVEDV (mL)	LVESV (mL)	LVEF (%)	LVFS (%)
Control group	6.45 ± 0.25	3.50 ± 0.16	0.618 ± 0.067	0.110 ± 0.015	82.15 ± 2.32	45.67 ± 2.55
DM group	7.85 ± 0.27^a	5.18 ± 0.26^a	1.067 ± 0.102^a	0.336 ± 0.049^a	68.65 ± 2.35^a	34.06 ± 1.74^a
NM-aFGF	7.47 ± 0.29^bc	4.75 ± 0.30^bc	0.929 ± 0.102^bc	0.263 ± 0.048^bc	71.82 ± 2.97^bc	36.46 ± 2.39^bc
NM-aFGF-PEG-lips	7.17 ± 0.31^bc	4.35 ± 0.27^bc	0.830 ± 0.098^bc	0.206 ± 0.035^bc	75.23 ± 3.28^bc	39.25 ± 2.83^bc
NM-aFGF + UTMD	7.48 ± 0.23^bc	4.73 ± 0.14^bc	0.927 ± 0.070^bc	0.262 ± 0.019^bc	71.61 ± 3.41^bc	36.60 ± 3.01^bc
NM-aFGF-PEG-lips + UTMD	6.83 ± 0.28^b	3.89 ± 0.19^b	0.726 ± 0.083^b	0.148 ± 0.021^b	79.46 ± 2.61^b	43.02 ± 2.55^b

Data are presented as Mean ± SD. ^ap < .05 vs control group; ^bp < .05 vs DM group; ^cp < .05 vs NM-aFGF-PEG-lips + UTMD. NM-aFGF-PEG-lips: non-mitogenic acidic fibroblast growth factor- PEGylated -liposomes; DM: diabetes mellitus; UTMD: ultrasound-targeted MB destruction.